The colonic crypts in rats reproduce themselves by symmetric fission at the base of the crypts, and proceeding upwards, generate two separate identical crypts. Recently we reported corrupted colonic crypt fission (CCCF) in rats with colonic carcinoma. Here we investigated whether CCCF also occurred in the colonic mucosa without carcinoma in carcinogen-treated rats.
Filed Swiss-roll sections from 35 male rats (25 treated with 1,2-dimethyhydrazine (DMH) suspended in EDTA solution, and 10 EDTA-treated) were reviewed. CCCF were regarded those with either asymmetric basal fission, asymmetric lateral sprouting/lateral fission, basal dilatations, or spatial aberrations of the normal (vertical) axis.
202 CCCF (38%) were recorded amongst 533 crypts with fission in DMH-treated rats, and only one CCCF (0.1%) was found amongst 571 crypts with fission in EDTA-treated rats (p<0.05). The basal aspect of four adenomas included in Swiss roll sections exhibited CCCF lined either with indigenous (non-dysplastic) epithelium or with dysplastic epithelium.
It was demonstrated that CCCF without dysplasia develop in carcinogen-treated SD rats. As judged by the figures presented, the possibility that the epithelium in those corrupted crypts was successively replaced by top-down growing dysplastic cells, could not be totally rejected. This is the first report showing that non-dysplastic CCCF may antedate the very early stages of colonic carcinogenesis in SD rats.
Citation: Rubio CA (2017) Corrupted colonic crypt fission in carcinogen-treated rats. PLoS ONE 12(3): e0172824. https://doi.org/10.1371/journal.pone.0172824
Editor: Hong Wang, Rutgers, the State Univesity of New Jersey, UNITED STATES
Received: December 14, 2016; Accepted: February 11, 2017; Published: March 8, 2017
Copyright: © 2017 Carlos A. Rubio. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper.
Funding: This study was supported by The Karolinska University Hospital Research and Development Fund No. 77147. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The author has declared that no competing interests exist.
While attempting to produce amyotropic lateral sclerosis by feeding nuts of Cycas circinalis (a tropical fern from a family of Cycadaceae), Laqueur et al. accidentally found that rats had developed colonic tumours . The same author subsequently demonstrated that the active carcinogen in these nuts was cycasin, a water-soluble á-glucoside of methylazoxymethano . That discovery, lead Ducky et al. to administer a structurally similar compound, namely 1,2-dimethylhydrazine (DMH), to induce tumours in the colon of rats . Since then, DMH and its carcinogenic metabolites (azoxymethane (AOM) and naethylazoxy methanol) have been commonly used to study morphology, pathogenesis, prevention and treatment in experimentally induced colonic tumours [4–6].
In both rodents and humans, most carcinomas evolve in the mucosal domain that occupies the vast majority of the colonic mucosa. This mucosal domain is built with crypts lined by goblet cells and columnar cells. Carcinomas in this vast domain are preceded by foci of dysplastic cell proliferations called conventional adenomas  or serrated adenomas . Progression to carcinoma is triggered by the accumulation of molecular aberrations  and by epigenetic modification of gene expression . The remnant mucosal domain, known as gut-associated lymphoid tissue (GALT) mucosa, is built with tiny organized lymphoid follicles . Puzzlingly, colonic GALT carcinomas are frequent in carcinogen-treated rats  but rare in humans .
Few in vivo studies have been done to unveil a possible morphologic stage preceding crypt dysplasia and adenomas in rodents. In this context Bird et al. detected in the colonic mucosa of rodents treated with carcinogens, gross changes in the pit pattern consisting in groups of 5 or more colonic crypts . These changes, called aberrant crypt foci (ACF), were regarded as potential markers of colorectal cancer risk as their incidence at an early time point highly correlated with end-point tumour incidence . Subsequently Nascimbeni et al. found that ACFs occurred more frequently in patients with CRC than in controls, and claimed that the phenomenon sustained their putative role as a preneoplastic marker . Nonetheless, the same group reported 10 years later that ACFs occurred less frequently in the distal colon of carcinogen-treated rats, which is the site of predilection for the development of adenomas and carcinomas. Their conclusion was that the growing features and allocation did not sustained the notion of ACF as a pre-neoplastic biomarker . In another study, Ochiai et al.  submitted that the specificity of ACF as tumor precursors should be questioned, partly because of their predominant location in the proximal colon where tumors do not develop, and by their gradual disappearance over time . Moreover, ACF frequently harboured Kras mutations, but rarely adenomatous polyposis coli (APC) mutations  strongly suggesting that the majority of ACF might not be true preneoplastic lesions.
Recently, while reviewing archival colonic sections from previous experiments in rats [18, 19], we noticed CCCF on top of GALT-carcinomas . These observations prompted us to investigate whether similar colonic crypt alterations could occur in the vast GALT-free mucosal domain in carcinogen-treated rats.
Materials & methods
Sprague-Dawley rats (Anticimex, Stockholm, Sweden) weighing 200 g were used. The animals were kept 5 rats/cage and were fed with a purine chow diet (R3; Ewos, Astra, Södertälje, Sweden). All rats were injected s.c. with 21 mg/kg of body weight of 1,2-dimethylhydrazine (DMH) hydrochloride salt (MW, 133–02) (Kebo, Stockholm, Sweden) suspended in 1 ml of EDTA solution (as a stabilizing agent) once a week for 27 weeks. The animals were weighted once in 2 weeks and the DMH dose adjusted accordingly.
Filed histological Swiss-roll sections from 35 male Sprague-Dawley (SD) were reviewed. Out of the 35 Sprague-Dawley rats, 25 were injected subcutaneously with a weekly dose of 21 mg/kg body weight of 1,2-dimethylhydrazine (DMH), hydrochloride salt Nw 133.02, for 27 weeks , and the remaining 10 SD rats were injected with EDTA for 27 weeks until sacrifice. The Swiss-roll technique was performed in 40 rats without visible tumours and in four rats showing small polyps.
Quantification of crypts with symmetric and asymmetric fission was performed on entire Swiss-roll sections.
Normal colonic crypts
The normal colon of untreated rats is built with test tube-shaped, close-packed crypts with their axis vertical to the muscularis mucosae. The colonic crypts reproduce themselves by symmetric fission, the division of which begins at the base of the crypts and proceeds upwards until they result into two identical, individual crypts  (Fig 1).
The crypts in the distal colon are easily recognized since they exhibit increased numbers of mucus-producing goblet cells in their lower segment. Mucus production is essential for lubricating dehydrated faeces on their way to the rectal ampullae.
Corrupted Colonic Crypt Fission (CCCF)
As CCC were regarded those with: i) Asymmetric basal fission, ii) Asymmetric lateral fission, iii) Asymmetric lateral sprouting, iv) Crypts with basal dilatation (≥ than twice the diameter of the normal lumen), and v) Crypts with spatial aberrations of the normal (vertical) axis (Figs 2–4)
Note L-shaped crypts (a and c), crypts with lateral sprouting (d and f), and with oblique axis (b and e) (DMH-treated rats, hematoxylin-eosin, a to f: x20).
Note low-grade dysplasia (b to e; d: detail of figure b). (DMH-treated rats, hematoxylin-eosin, a, b x20, c, d, e x40).
I) Frequency of CCCF in DMH-treated, and EDTA-treated rats.
Table 1 shows that 202 CCCF were recorded in the 25 DMH-treated rats (8.08 CCCF/DMH-treated rat, range 26–1), and one CCCF among the 10 EDTA-treated rats (0.1 CCCF/ rat, range 1–0). The difference of CCCF between DMH-treated rats and EDTA-treated rats was significant (p<0.05).
II) Frequency of CCCF per crypts with fission in DMH-treated, and EDTA-treated rats.
Table 1 indicates that 202 CCCF (37.9%) were recorded out of 533 crypts with fission in DMH-treated rats, and only one CCCF (0.1%) out of 571 crypts with fission in EDTA-treated rats. The difference in numbers of CCCF/crypts with fission between DMH-treated rats and EDTA-treated rats was significant (p<0.05).
The four polyps included in the Swiss roll sections were conventional adenomas, two of them with high-grade dysplasia (Fig 5). The basal aspect in these adenomas exhibited corrupted crypts, lined either with non-dysplastic (indigenous) epithelium or with dysplastic epithelium (Fig 5).
a: Note non-dysplastic corrupted crypts underneath arrows, b: Two corrupted crypts with high grade dysplasia, the one on the left with additional asymmetric lateral fission (at arrows), c-f: Corrupted colonic crypts lined with dysplastic epithelium, d: Three-arm crypt, at arrow. (DMH-treated rats, hematoxylin-eosin, a, b: x10, c, d x10, e, f: x40).
The results of the present survey showed that DMH-treated SD rats had a significantly higher number of CCCF than EDTA-treated SD rats. These findings strongly suggest that the carcinogen used in the experiment was crucial for the induction of CCCF in SD rats.
The CCCF described here differs from the appearance of aberrant crypt foci (ACF) in carcinogen-treated rodents reported by Bird et al.  inasmuch as the latter was detected following staining with methylene blue of the surface of the colonic mucosa. Thus, Bird et al assessed the ACF pattern by observing the mucosa “from the top”  and not, from the “side” in well-oriented histological sections, as in the present study.
According to Ghirardi et al.  and Ochiai et al. , the ACF phenomenon is infrequently found in the distal colon, the site of predilection for adenomas and carcinomas in carcinogen-treated rats. At variance with ACF, we found that CCCF predominantly evolving in the mid-distal colon, the site where neoplasias often develop in carcinogen-treated rats.
Recently Tan et al. found asymmetrical crypt budding in the colon of C57BL/6 mice . It should be mentioned that in order to isolate colonic crypts from the lamina propria, the muscularis mucosae and the submucosa, the authors used an invasive method; colons were kept and rinsed on ice, incubated in sodium hypochlorite (5 minutes), in EDTA (90 minutes), transferred to PBS (20°C), shaken vigorous (5 times), and centrifuged (34g, 5 minutes). With this “ex-vivo” procedure, the authors found asymetic crypt buddings in untreated mice. Tan et al method  differs from the method described in this communication, inasmuch as the colons were fixed immediately after sacrifice, in formaldehyde. The crypts were subsequently observed “in situ”, in conventionally stained sections, a method less amenable to develop artifacts.
During crypt renewal, the stem cells at the crypt bottom generate amplifying daughter cells that proliferate and differentiate while migrating upwards [21, 23, 24]. Wnt signaling is high at the bottom (where SCs reside) and low at the top. In contrast, the adenomatous polyposis coli (Apc) gene concentration is low at the crypt bottom and high at the top (the domain of differentiated cells) [21, 23, 24]. The Apc gene normally down-regulates Wnt signalling. Hence, Wnt and Apc gradients are important in crypt formation and regulation. Since both Apc and Wnt signalling components are required for mitosis, a zone emerges in the lower crypt where conditions are optimal for maximal cell division and mitosis orientation resulting in symmetric crypt fission [21, 23, 24].
In 1985, St Clair and Osborne isolated colonic crypts from young rats by the aid of a microdissection technique . Crypts were scored as ordinary or in fission. The percentage of crypts in fission (PCF) reached peak values of 52% in the colon at 21-day post-parturition. From this time-onwards, the PCF dropped until the adult value of approximately 7% was reached. During this same period, the number of crypts increased from 2.2 X 10 to 6.5 X 10 in the colon. Thus, an inverse relationship was found between the percentage of crypts in fission and the number of crypts. Distribution of fissure heights in fission crypts did not change as the animal aged. The majority of the fissures were found in the lower 1/4 of the fission crypts, suggesting that as soon as the fissure extends beyond the stem cell zone, division into two crypts soon occurs . More recently, Boman and Fields  found that APC-mutation-induced changes in the counter-current-like mechanism, triggering expansion of proliferative populations, driving crypt fission premalignant changes and adenoma development. This proliferative shift in normal-appearing crypts, not yet dysplastic, was the earliest-known biological alteration. Notably, crypts exhibiting this proliferative abnormality (e.g., FAP crypts) did not show any microscopically visible changes at histology. According to Boman and Fields  mutations in the APC gene, found in most colorectal cancers, would cause abnormal crypt production, disorientation of the crypts, and increased crypt production leading to colorectal adenomas. These authors  claimed that the crypts began to show abnormalities in histology only when they became dysplastic, i.e. during the formation of premalignant adenomas, which had a second hit at the APC locus. In present work, we found in addition, that colonic crypts of carcinogen-treated SD rats may also portray histological abnormalities in the absence of dysplastic cell features.
In conclusion, it was demonstrated that CCCF without dysplasia develop in carcinogen-treated SD rats. As judged by the figures presented, the possibility that the epithelium in those corrupted crypts was successively replaced by top-down growing dysplastic cells, could not be totally rejected. This is the first report showing that non-dysplastic CCCF may antedate the very early stages of colonic carcinogenesis in SD rats.
- Conceptualization: CAR.
- Data curation: CAR.
- Formal analysis: CAR.
- Funding acquisition: CAR.
- Investigation: CAR.
- Methodology: CAR.
- Project administration: CAR.
- Resources: CAR.
- Software: CAR.
- Supervision: CAR.
- Validation: CAR.
- Visualization: CAR.
- Writing – original draft: CAR.
- Writing – review & editing: CAR.
- 1. Laqueur GL, Mickelsen O, Whiting MG, Kurkland LT. Carcinogenic properties of nuts from Cycas Circinalis l. indigenous to Guam J Natl Cancer Inst 1963; 3: 919–995.
- 2. Laqueur GL. The induction of intestinal neoplasms in rats with the glycoside cycasin and its aglycone. Virchows Arch Pathol Anat. Physiol Klin Med 1965; 340:151–163.
- 3. Druckrey H, Preussmann R, Matzkies F, Ivankovic S. Selective production of intestinal cancer in rats by 1,2-dimethylhydrazine. Naturwissenschaften 1967; 54:285–286.
- 4. Rubio CA, Wallin B, Ware J. Sveander M, Duvander A. Effect of indomethacin in autotransplanted colonic tumors. Dis Colon Rectum 1989; 32: 488–491. pmid:2791785
- 5. Rubio CA, Rivera F. Quantification of acid mucins in the descending colon of rats having simultaneously growing colonic tumors. APMIS 1991; 99: 993–996. pmid:1958356
- 6. Rubio CA. Apoptotic differences in experimentally induced colorectal rat tumours. Apoptosis. 1998; 3: 35–39. pmid:14646516
- 7. Rubio C A, Nylander G, Santos M. Experimental colon cancer in the absence of intestinal contents in Sprague-Dawley rats. J Natl Cancer Inst 1980; 64: 569–572. pmid:6928242
- 8. Rubio CA. Traditional serrated adenomas and serrated carcinomas in carcinogen-treated rats. J Clin Pathol 2016 Aug 26. [Epub ahead of print].
- 9. Femia AP, Luceri C, Toti S, Giannini A, Dolara P, Caderni G. Gene expression profile and genomic alterations in colonic tumours induced by 1,2-dimethylhydrazine (DMH) in rats. BMC Cancer. 2010; 10:194–198. pmid:20459814
- 10. Jang H, Mason JB, Choi SW. Genetic and epigenetic interactions between folate and aging in carcinogenesis. J Nutr 2005; 135(12 Suppl):2967S–2971S. Review. pmid:16317156
- 11. Deasy JM, Steele G Jr, Ross DS, Lahey SJ, Wilson RE, Madara J. Gut-associated lymphoid tissue and dimethylhydrazine-induced colorectal carcinoma in the Wistar/Furth rat. J Surg Oncol 1983; 124: 36–40.
- 12. Martin MS, Hammann A, Martin F. Gut-associated lymphoid tissue and 1,2-dimethylhydrazine intestinal tumors in the rat: a histological and immunoenzymatic study. Int J Cancer 1986; 38: 75–80. pmid:3522439
- 13. Rubio CA, Schmidt PT. Gut-associated lymphoid tissue (GALT) Carcinoma or dome Carcinoma? Anticancer Res 2016; 36: 5385–5387. pmid:27798903
- 14. Bird RP, McLellan EA, Bruce WR. Aberrant crypts, putative precancerous lesions, in the study of the role of diet in the aetiology of colon cancer. Cancer Surv 1989; 8:189–200. pmid:2680070
- 15. Nascimbeni R, Villanacci V, Mariani PP, Di Betta E, Ghirardi M, Donato F, et al. Aberrant crypt foci in the human colon: frequency and histologic patterns in patients with colorectal cancer or diverticular disease. Am J Surg Pathol. 1999; 23:1256–1263. pmid:10524527
- 16. Ghirardi M, Nascimbeni R, Villanacci V, Fontana MG, Di Betta E, Salerni B. Azoxymethane-induced aberrant crypt foci and colorectal tumors in F344 rats: sequential analysis of growth. Eur Surg Res 1999; 31:272–280. pmid:10352356
- 17. Ochiai M, Hippo Y, Izumiya M, Watanabe M, Nakagama H. Newly defined aberrant crypt foci as a marker for dysplasia in the rat colon. Cancer Sci 2014; 105:943–950. pmid:24827115
- 18. Rubio CA, Nylander G., Sveander , Duvander A, Alun ML. Minimal invasive carcinoma of the colon in rats. Am J Pathol 1986; 123:161–165. pmid:3963149
- 19. Shetye JD, Rubio CA, Harmenberg U, Ware J, Duvander A, Mellstedt HT. Tumor-associated antigens common to humans and chemically induced colonic tumors of the rat. Cancer Res 1990; 50: 6358–6363. pmid:2400995
- 20. Rubio CA. Three pathways of colonic carcinogenesis in rats. Anticancer Res 2017;37:15–20. pmid:28011469
- 21. Boman BM and Fields JZ. An APC:WNT Counter-Current-Like Mechanism Regulates Cell Division Along the Human Colonic Crypt Axis: A Mechanism That Explains How APC Mutations Induce Proliferative Abnormalities That Drive Colon Cancer Development. Front Oncol 2013; 3:244–250. Review pmid:24224156
- 22. Tan CW, Hirokawa Y, Gardiner BS, Smith DW, Burgess AW. Colon cryptogenesis: asymmetric budding. PLoS One. 2013;8:e78519. pmid:24205248
- 23. Rubio CA. Putative stem cells in mucosas of the esophago-gastrointestinal tract. Chapter 10. In: Singh SR, editor. Stem cell, regenerative medicine and cancer. Haupauge, NY, USA: Nova Science Publishers, Inc. 2011:279–308.
- 24. Shih IM, Wang TL, Traverso G, Romans K, Hamilton SR, Ben-Sasson S, et al. Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci U S A. 2001; 98: 2640–2545. pmid:11226292
- 25. St Clair WH, Osborne JW. Crypt fission and crypt number in the small and large bowel of postnatal rats. Cell Tissue Kinet. 1985;18: 255–262. pmid:3986870